Art
J-GLOBAL ID:200902247337761140   Reference number:08A0626177

Docetaxel Plus Prednisolone for the Treatment of Metastatic Hormone-refractory Prostate Cancer: A Multicenter Phase II Trial in Japan

転移性ホルモン抵抗性前立腺癌の治療におけるドセタキセル+プレドニゾロン 日本における多施設第2相試験
Author (7):
Material:
Volume: 38  Issue:Page: 365-372  Publication year: May. 2008 
JST Material Number: W2222A  ISSN: 0368-2811  Document type: Article
Article type: 原著論文  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0626177&from=J-GLOBAL&jstjournalNo=W2222A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for tumors  ,  Urogenital tumors(=neoplasms)  ,  Clinical application of antitumor(=antineoplastic)drugs 
Substance index (2):
Substance index
Chemical Substance indexed to the Article.
Reference (30):
  • American Cancer Society. Cancer Facts and Figures 2007. Available at: http://www.cancer.org/docroot/stt/stt_0.asp
  • Ohshima A, Kuroishi T, Tajima K. Cancer Statistics White Paper-Disease/Death/Prognosis 2004. Tokyo: Shinoharashinsha 2004; 201-217, 220-234 (in Japanese).
  • Japanese Ministry of Health, Labour and Welfare, 2005. Summary of Vital Statistics. Available at: www.mhlw.go.jp/toukei/saikin/hw/jinkou/suii05/deth15.html
  • Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502-12.
  • Yagoda A, Petrylak D. Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 1993; 71 (3 Suppl.): 1098-109.
more...

Return to Previous Page